Cheng Xiang Dai
Corporate Officer/Principal bei CELLULAR BIOMEDICINE GROUP, INC.
Profil
Cheng Xiang Dai currently works at AbelZeta Pharma, Inc., as General Manager-Stem Cell Business Unit.
Dr. Dai also formerly worked at Venturepharma, Inc., as Medical Director.
Dr. Dai received his graduate degree from Zhengzhou University.
Aktive Positionen von Cheng Xiang Dai
| Unternehmen | Position | Beginn |
|---|---|---|
| CELLULAR BIOMEDICINE GROUP, INC. | Corporate Officer/Principal | 11.07.2013 |
Ehemalige bekannte Positionen von Cheng Xiang Dai
| Unternehmen | Position | Ende |
|---|---|---|
Venturepharma, Inc.
 Venturepharma, Inc. Pharmaceuticals: MajorHealth Technology Venturepharma, Inc. manufactures pharmaceutical products. It offers VP discovery, API development and outsourcing, biopharmaceuticals discovery, RX and OTC. The firm provides products for oncology, CNS, dermnova, diabetes, cardiovascular, respiration and vaccine. The company was founded in 1998 and is headquartered in Haidian, China. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Cheng Xiang Dai
| Zhengzhou University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Venturepharma, Inc.
Venturepharma, Inc. Pharmaceuticals: MajorHealth Technology Venturepharma, Inc. manufactures pharmaceutical products. It offers VP discovery, API development and outsourcing, biopharmaceuticals discovery, RX and OTC. The firm provides products for oncology, CNS, dermnova, diabetes, cardiovascular, respiration and vaccine. The company was founded in 1998 and is headquartered in Haidian, China. | Health Technology |
AbelZeta Pharma, Inc.
 AbelZeta Pharma, Inc. BiotechnologyHealth Technology Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in Rockville, MD. | Health Technology |
